Equities

Anatara Lifesciences Ltd

ANR:ASX

Anatara Lifesciences Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)0.044
  • Today's Change0.00 / 0.00%
  • Shares traded27.96k
  • 1 Year change+67.36%
  • Beta1.0717
Data delayed at least 20 minutes, as of May 24 2024 03:36 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Events & Activity

  • ANR:ASX price moved over -10.00% to 0.036
  • ANR:ASX price falls below 50-day moving average to 0.036 at 12:14 BST
  • ANR:ASX price rises above 15-day moving average to 0.044 at 16:36 BST

Key statistics

As of last trade Anatara Lifesciences Ltd (ANR:ASX) traded at 0.044, -12.00% below its 52-week high of 0.05, set on May 01, 2024.
52-week range
Today
0.0207Nov 03 20230.05May 01 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open0.045
High0.045
Low0.044
Bid0.041
Offer0.044
Previous close0.044
Average volume35.61k
Shares outstanding191.14m
Free float130.51m
P/E (TTM)--
Market cap8.03m AUD
EPS (TTM)-0.014
AUD
Data delayed at least 20 minutes, as of May 24 2024 03:36 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.